- Home
- VYNE vs CCM Comparison
VYNE vs CCM Comparison
Compare VYNE & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VYNE | CCM |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0M | 17.6M |
| IPO Year | 2018 | 2009 |
Fundamental Metrics
Financial Performance| Metric | VYNE | CCM |
|---|---|---|
| Price | $0.59 | $3.59 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 418.2K | 5.2K |
| Earning Date | 03-05-2026 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $524,000.00 | ★ $51,056,841.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.29 | N/A |
| 52 Week Low | $0.28 | $3.50 |
| 52 Week High | $2.94 | $10.77 |
Technical Indicators
Market Signals| Indicator | VYNE | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 68.94 | 38.39 |
| Support Level | $0.55 | $3.50 |
| Resistance Level | $0.57 | $4.11 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 91.01 | 9.35 |
Price Performance
Historical ComparisonAbout VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.